|

|
 |
| |
 |
 |
| |
 |
 |
| Fellow : |
Mr Liaquat Suleman-Verjee |
| Title : |
Tenascin-C and the pathogenesis of Dupuytren’s disease |
| Supervisor : |
Professor Jagdeep Nanchahal |
| Lead Institution : |
Kennedy Institute of Rheumatology Imperial College London |
| Start date : |
October 2007 |
| Duration : |
24 months |
| Award : |
£93,805 over two years |
|
Dupuytren’s disease is a common inheritable disorder, mainly affecting the hand. The digits develop progressive flexion contractures and hand function is significantly impaired. The current mainstay of treatment is surgical excision of the affected tissues but recurrence following excision is seen in approximately 40% of patients. Replacing the palmar skin with grafts obtained from a non-palmar site on the body virtually abolishes recurrence. Based on this well-established surgical observation, we have developed a novel in vitro model, which replicates these interactions between skin cells and the contractile cells responsible for Dupuytren’s disease. We have also identified a molecule (tenascin-C), which may control the signalling between these cell types.
This study is designed to elucidate the exact role of tenascin-C in Dupuytren’s disease and go on to work out how this molecule alters the interactions between skin cells and the cells in Dupuytren’s disease.
Previous attempts to understand the mechanisms involved in Dupuytren’s disease have not led to viable therapeutic interventions. Our aim is to understand the basis of a well-established surgical phenomenon and, based on this knowledge, develop modalities for controlling this common, disabling disorder of the hand.
Kindly supported by the Freemasons' Grand Charity.
|
|
 |
|
| |
 |
| |
 |
 |
| Fellow : |
Dr Husam Bella |
| Title : |
Identification of susceptibility genes to Keloid scarring |
| Supervisor : |
Professor W.E.R. Ollier |
| Lead Institution : |
Centre for Integrated Genomic Medical Research (CIGMR) at University of Manchester |
| Start date : |
February 2007 |
| Duration : |
24 months |
| Award : |
£98,748 over two years |
|
Keloids are benign dermal collagenous lesions that arise in the dermis during a prolonged wound healing process in individuals with a genetic predisposition. Keloid disease causes hugely disfiguring and symptomatic lesions in affected individuals with little hope of successful treatment as it is highly recurrent. The sufferers face serious aesthetic, physical, psychological and social consequences that may culminate in substantial emotional and financial costs. Although the rate of occurrence of keloid disease is reported to be higher in the Black population it affects all races and managing the resulting disfigurement is a frustrating challenge. The increased familial clustering in keloid disease, its increased prevalence in certain races and in identical twins suggests a strong genetic predisposition to keloid formation. Understanding the genetic basis may provide future prognostic and diagnostic advice to patients and help to develop novel therapeutic regimes for treatment of skin fibrosis.
Generously supported by ICAP plc.
|
|
 |
|
| |
 |
| |
 |
 |
| Researcher : |
Mr Ves Agrawal |
| Title : |
Ex vivo Gene Therapy of Microvascular Free Flaps for the Treatment of Breast Cancer |
| Supervisor : |
K.J Harrington |
| Lead Institution : |
The Institute for Cancer Research, The Royal Marsden Hospital |
| Start date : |
November 2006 |
| Duration : |
12 months |
| Award : |
£9,500 over one year |
|
Breast Cancer is now the second commonest cancer in the UK and by far the most common cancer in women. For women, the lifetime risk of developing breast cancer is now 1 in 9. Over 41 000 women are diagnosed with breast cancer each year and more than 1000 women die from the disease every month in the UK alone. The current mainstay of treatment for such cancer is surgery with a combination of radiotherapy, chemotherapy and hormone therapy. Following surgical removal of the cancer, we are left with a defect that needs to be filled. Using reconstructive surgery techniques, we move tissue from an area of the body where it is expendable to the defect in order to aesthetically reconstruct the breast. Ordinarily, this tissue is used simply to fill the space of the cavity and provide the material to fashion a new breast. In this project we seek to modify the tissue after it has been removed from the donor area and before it has been placed into the cavity by introducing genes that will have an anti-cancer effect. This is achieved by using pieces of DNA (called plasmids) or viruses to make the free flap produce a protein that destroys cancer cells and, therefore, stops the cancer returning.
Generously supported by ICAP plc.
|
|
 |
|
| |
 |
| |
 |
 |
| Fellows : |
Dr Tammy Boyce and Dr. Claire Wardle |
| Title : |
Media coverage and audience reception of people with disfigurement or visible loss of function |
| Supervisor : |
Professor Justin Lewis |
| Lead Institution : |
School of Journalism, Media and Cultural Studies, Cardiff University |
| Start date : |
September 2006 |
| Duration : |
24 months |
| Award : |
£86,223 over two years, with the Wales Office for Research and Development |
|
This research is aimed at understanding how people with disfigurements, their stories and their daily experiences are portrayed on primetime television. This research will explore whether television can help people with disfigurements, in terms of identifying with others in similar situations, learning about support outlets, or feeling accepted by the wider community. Does television fulfil those roles now? If not, are there ways that television programme makers could improve output which would consider possible recommendations suggested by people with disfigurements. One of the aims of the Healing Foundation is to understand ‘the processes of psychological adaptation and recovery’, and the media can potentially have a significant impact on these processes.
|
|
 |
|
 |
 |
| Fellow : |
Mr Joseph Hardwicke |
| Title : |
Polymer therapeutics to modify cellular responses in impaired human wound healing |
| Supervisor : |
Professor David W. Thomas |
| Lead Institution : |
Wound Biology Group, Department of Oral Surgery, Medicine & Pathology, School of Dentistry, Cardiff |
| Start date : |
June 2006 |
| Duration : |
24 months |
| Award : |
£84,284 over two years, with the Wales Office for Research and Development |
|
Impaired wound healing in the skin may occur after trauma or elective surgery and represents a huge clinical problem. Chronic skin wounds have been estimated to occur in 3% of the Welsh population and are increasing with the rising ageing population. Described as skin wounds that fail to heal, they represent a significant cause of disability and distress amongst the aged. Whilst the exact cause(s) of these wounds are unclear, the inability of cells within the wound to function properly is believed to be responsible for their failure to heal. Our attempts to treat these wounds are principally based around the applications of dressings or pharmaceutical treatment of the wound surface; such interventions have been largely unsuccessful, to date. Recently, the development of novel methods of delivering biological agents (using long chain polymers) may aid in the delivery of various biological molecules/pharmaceuticals to treat such wounds. We have identified one key molecule, called Hepatocyte Growth Factor (HGF), which may help the cells from chronic wounds regain their normal healing properties. The aim of this research is to investigate whether the development of polymers containing HGF can help cells from chronic wounds to regain their normal wound healing properties.
|
|
 |
|
| |
 |
| |
 |
 |
| Fellow : |
Mr Darryl Dunn |
| Title : |
Chemokine Roles in Melanoma Metastasis |
| Supervisor : |
Dr DO Bates |
| Lead Institution : |
University of Bristol |
| Award date : |
November 2005 |
| Start date : |
1 January 2006 |
| Duration : |
24 months |
| Award : |
£100,000 over two years, with the British Association of Plastic Surgeons |
|
Of the three predominant forms of skin cancer Melanoma is the most dangerous. There are around 5,600 new cases diagnosed each year in the UK of which around 1,600 will die of the disease. It is the spread of the disease, to other parts of the body, that causes patients to die. The rates for Melanoma have been rising for the last 30 years and are rising faster than any other cancer in the UK. This project aims to study certain chemicals in order to predict which cancers will spread. The next stage will be to block these chemicals to stop the cancer spreading. Predicting which cancers will spread would alleviate stress to patients and free up vital clinical time presently used in following patients. If we can stop the spread of cancer we can prevent a significant number of deaths from cancer. It would also reduce the amount of surgery patients now undergo, a significant amount of which fails to halt the progress of the disease. Furthermore the degree of surgery is also likely to be reduced if we can identify which cancers are not likely to spread. This will significantly reduce the disfigurement and subsequent reconstruction required, enabling healing to occur more quickly.”
Please click here to view Darryl's latest report.
|
|
 |
|
| |
 |
| |
 |
 |
| Fellow : |
Mr Chris Milner |
| Title : |
Novel targets for the prevention of endothelial leakage in severe burns |
| Supervisor : |
Dr Nicholas Brindle |
| Lead Institution : |
University of Leicester |
| Award date : |
March 2005 |
| Start date : |
1 October 2005 |
| Duration : |
24 months |
| Award : |
£100,000 over two years, with the Royal College of Surgeons of England |
|
Major burn injury produces inflammation that
effects the entire body. This leads smaller
blood vessels to leak fluid into the surrounding
tissue causing organs to swell and stop working
properly. This is a major factor in contributing
to the mortality associated with extensive
burns. Recently a control mechanism counteracting
this has been hinted at, taking place within
the vessel wall linings of cells and involving
a protein called VE-PTP. We wish to understand
more about VE-PTP and its instrumental part
in preventing excessive fluid leak and to explore
ways that drugs can enhance its effectiveness
to resist inflammation caused by severe burns.
Annual Report now available – click here.
|
|
 |
|
| |
 |
| |
 |
 |
| Fellow : |
Mr Chris Baldwin |
| Title : |
A novel artificial skin – harnessing the pro-angiogenic effects of fibrin |
| Supervisor : |
Dr J Dye / Mr A Grobbelaar |
| Lead Institution : |
RAFT, Mount Vernon Hospital, Northwood, Middlesex |
| Award date : |
May 2005 |
| Start date : |
1 August 2005 |
| Duration : |
24 months |
| Award : |
£100,000 over two years, with the Royal College of Surgeons of Edinburgh |
|
The project aims to develop a second generation synthetic dermal replacement
that improves ‘skin take’ by actively promoting angiogenesis (the
synthesis of new blood vessels), a crucial step in wound healing. On completion
of the research, an effective new product should be ready to enter human clinical
trials. If successful, this project will transform the outcome of chronic wounds,
in particular burns, accelerating wound healing, reducing mortality and improving
scarring and function.
Annual Report now available – click here.
|
|
 |
|
| |
 |
 |
|
 |
 |
 |
 |
 |
| Fellow : |
Mr Parbinder Sahota |
| Title : |
Tackling the problem of angiogenesis in
tissue-engineered skin |
| Supervisor : |
Prof S MacNeil |
| Lead Institution : |
University of Sheffield |
| Start date : |
August 2002 |
| Duration : |
24 months |
| Award : |
£80,000
over two years, with the Royal
College of Surgeons of England |
|
There is a need for laboratory-grown skin
for patients who have suffered full-thickness
skin loss such as follows burn injuries and
also in cases where extensive reconstructive
surgery is required, most commonly, in patients
who have suffered contracture of wounds following
burn injuries. Considerable progress has
been made in developing laboratory-grown
skin using the patients own skin cells (keratinocytes
and fibroblasts) within a sterilised human
donor skin from which all donor cells have
been removed. However, these grafts often
lose their blood supply which leads to loss
of the grafts on the patients. This study
aims to develop strategies to improve blood
flow and blood vessel development (angiogenesis)
in reconstructed human skin by establishing
in vitro models.
Final Report now available click
here.
|
|
 |
|
 |
 |
 |
 |
 |
| Fellow : |
Miss Claire Phillips |
| Title : |
Establishing the
psychosocial needs of people affected by
burns: Towards evidence-based psychosocial
support programmes following burn injury |
| Supervisor : |
Prof
N Rumsey |
| Lead Institution : |
Centre for Appearance Research,
University of the West of England
(UWE) |
| Start date : |
June
2003 |
| Duration : |
24 months |
| Award : |
£80,000
over two years |
|
Research indicates that a significant proportion
of adult burn patients may still have psychological
distress up to two years after discharge
from hospital. This project aims to establish
the psychosocial needs of burn-injured patients
as they move from an in-patient to out-patient
care environment and to develop support programmes
based on the evidence attained.
Publications:
Considerations for the provision of psychosocial services for families following paediatric burn injury - a quantitative study. Phillips C, Rumsey N. Burns 2007 Jul 5.
Considerations for psychosocial support following burn injury - a family perspective. Phillips C, Fussell A, Rumsey N. Burns 2007 Jul 10.
Phillips C (in press) Psychological and social aspects of burn injury. Cambridge Handbook of Psychology, Health, and Medicine (2nd Edition)
|
|
 |
|
 |
 |
 |
|
 |
 |
|